Related Experiment Video
Updated: Aug 13, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Nevirapine-related adverse events in a patient receiving a fixed-drug combination pill
Olusoji J Daniel1, Alysa B Krain, Shamsideen A Ogun
1Centre for Special Studies Nigeria, Olabissi Onabanjo University Teaching Hospital, Sagamu, Ogun State, Nigeria. sojidaniel@yahoo.com
Abstract:
Nevirapine associated rash has been well described in the Caucasian population. With increasing access to antiretroviral treatment--especially a fixed dose combination--by people living with HIV/AIDS in developing countries, there is a need to emphasize the lead in doses of nevirapine. We strongly recommend a warning label on the bottle advising patients on the lead-in period and the signs and symptoms of significant rash.
Related Concept Videos
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Antiviral Nucleoside Inhibitors
Pharmacokinetics: Drug–Drug Interactions
Drug toxicity: Idiosyncratic Reactions
Drug toxicity: Drug–Drug Interaction
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
